Video Experimental Relacionado
Updated: Feb 11, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.5K
La administración de corticosteroides en el asma: desde los prescriptores individuales hasta el cambio a nivel de
Vincent Gallub1, Linda Rogers, Boram Kim
1Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Current opinion in pulmonary medicine
|February 10, 2026
Resumen
El uso excesivo de corticosteroides en el asma, incluidas las formas sistémicas e inhaladas, conduce a daños poco reconocidos. La administración de corticosteroides ofrece una estrategia para mitigar estos riesgos en el manejo del asma.
Área de la Ciencia:
- Pulmonología Pulmonología.
- Farmacología Farmacología.
- Sistemas de Salud Ciencia de los Sistemas de Salud.
Sus antecedentes:
- Se reconocen los efectos adversos de los corticosteroides sistémicos crónicos para el asma.
- Los datos emergentes revelan daños similares de los cursos cortos de corticosteroides sistémicos (SCS) y las altas dosis de corticosteroides inhalados (ICS).
Objetivo del estudio:
- Para revisar los daños poco reconocidos del uso excesivo de corticosteroides en el asma.
- Para resaltar la administración de corticosteroides como una estrategia para abordar estos daños.
Principales métodos:
- Revisión de la literatura de los avances recientes en los efectos adversos de los corticosteroides en el asma.
- Resumen de las llamadas para la administración de corticosteroides en el cuidado del asma.
- Descripción de las estrategias basadas en sistemas para reducir el uso excesivo de corticosteroides.
Principales resultados:
- El uso excesivo de corticosteroides, que abarca SCS e ICS, presenta riesgos significativos para la salud en pacientes con asma.
- Existe la necesidad de una mayor conciencia de los daños tanto a corto como a largo plazo del uso de corticosteroides.
- Existen estrategias efectivas para reducir el uso excesivo de corticosteroides.
Conclusiones:
- Esta revisión proporciona una comprensión actualizada de los daños asociados a los corticosteroides para los proveedores de atención primaria, aguda y especializada.
- Sirve como una guía para la implementación de la administración de corticosteroides basada en el médico individual y el sistema de salud.
- La promoción de la administración puede mejorar el cuidado del asma al minimizar los eventos adversos relacionados con los corticosteroides.
Videos de Conceptos Relacionados
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:26COPD: Management Using Bronchodilators and Corticosteroids
831
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
831
01:24Asthma-III: Symptoms and Complications
3.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.4K
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:20Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
01:26Asthma-II: Pathophysiology and Classification
4.4K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.4K